Law360, New York ( July 15, 2013, 11:08 AM EDT) -- Reading U.S. Supreme Court Justice Clarence Thomas' opinion in Myriad, one might get the sense that it was the easiest case the court has decided in a long while. The court seemed to say: Of course isolated human genes are a product of nature and cannot be patented;[1] of course, cDNA[2] is self-evidently something new and must be patent-worthy. In many ways, this is true. As expressed by the numerous press accounts commenting on the decision, there is an intuitive sense of unfairness in the notion that our DNA — the stuff and substance of our existence — can be owned and exploited by someone else....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.